Enhanced inhibitory effect of dc-cik cells on lung adenocarcinoma via anti-tim-3 antibody and antiprogrammed cell death-1 antibody and possible mechanism

HIGHLIGHTS

  • who: Adenocarcinoma via Anti-Tim- and collaborators from the The Second Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China have published the article: Enhanced Inhibitory Effect of DC-CIK Cells on Lung Adenocarcinoma via Anti-Tim-3 Antibody and Antiprogrammed Cell Death-1 Antibody and Possible Mechanism, in the Journal: Evidence-Based Complementary and Alternative Medicine of 31/07/2022
  • what: The study investigated whether anti-Tim-3 and anti-PD1 antibodies could enhance the tumor-specific immune_response of DC-CIK cells and produce a more substantial . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?